Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

Online First

May 14, 2018

Correspondence
Checkpoint inhibitor-induced polymyalgia rheumatica controlled by cobimetinib, a MEK 1/2 inhibitor

Karmela Kim Chan, Anne R Bass

doi: 10.1136/annrheumdis-2018-213672

May 05, 2018

Correspondence response
Response to: ‘Pitfalls of antinuclear antibody detection in systemic lupus erythematosus: the positive experience of a national multi-center study’ by Pregnalato et al

David S Pisetsky, Diane M Spencer, Peter E Lipsky, Brad H Rovin

doi: 10.1136/annrheumdis-2018-213582
Correspondence
To DAPSA or not to DAPSA? That is not the question

Monika M Schoels, Josef S Smolen, Daniel Aletaha

doi: 10.1136/annrheumdis-2018-213548
Correspondence response
Response to: ‘Variation in antinuclear antibody detection by automated indirect immunofluorescence analysis’ by van Hoovels et al

David S Pisetsky, Diane M Spencer, Peter E Lipsky, Brad H Rovin

doi: 10.1136/annrheumdis-2018-213558

May 03, 2018

Correspondence
Tofacitinib in steroid-dependent relapsing polychondritis

Alexey D Meshkov, Pavel I Novikov, Evgeny V Zhilyaev, Ilia David J Ilevsky, Sergey V Moiseev

doi: 10.1136/annrheumdis-2018-213554
Correspondence response
Response to: ‘Time to personalise the treatment of anti-MDA-5 associated lung disease’ by Lake et al

Valérie Leclair, Ingrid E Lundberg, Anna Tjärnlund

doi: 10.1136/annrheumdis-2018-213519
Correspondence
Checkpoint inhibitor-associated immune arthritis

Laurent Arnaud, Bénédicte Lebrun-Vignes, Joe-Elie Salem

doi: 10.1136/annrheumdis-2018-213470

April 28, 2018

Correspondence
Missing pebble in the mosaic of rheumatic diseases and mental health: younger does not always mean happier

Alessia Alunno, Paul Studenic, Dieter Wiek, Petra Balážová, Daniel Aletaha

doi: 10.1136/annrheumdis-2018-213611
Correspondence response
Response to: ’Unending story of the indirect immunofluorescence assay on HEp-2 cells: old problems and new solutions?' by Meroni et al

David S Pisetsky, Diane M Spencer, Peter E Lipsky, Brad H Rovin

doi: 10.1136/annrheumdis-2018-213537

April 25, 2018

Correspondence
Pitfalls of antinuclear antibody detection in systemic lupus erythematosus: the positive experience of a national multicentre study

Francesca Pregnolato, Maria Orietta Borghi, Pier Luigi Meroni Forum Interdisciplinare per la Ricerca sulle Malattie Autoimmuni (FIRMA) Study Group

doi: 10.1136/annrheumdis-2018-213516

April 20, 2018

Correspondence
Variation in antinuclear antibody detection by automated indirect immunofluorescence analysis

Lieve Van Hoovels, Sofie Schouwers, Stefanie Van den Bremt, Xavier Bossuyt

doi: 10.1136/annrheumdis-2018-213543

April 17, 2018

Correspondence
Unending story of the indirect immunofluorescence assay on HEp-2 cells: old problems and new solutions?

Pier Luigi Meroni, Edward K Chan, Jan Damoiseaux, Luís Eduardo Coelho Andrade, Xavier Bossuyt, Karsten Conrad, Xavier Mariette, Joanna Sheldon, Johan Rönnelid, Marvin J Fritzler On behalf of the members of the committees

doi: 10.1136/annrheumdis-2018-213440

April 13, 2018

Correspondence response
Response to: Can ultrasound of the major salivary glands assess histopathological changes induced by treatment with rituximab in primary Sjögren’s syndrome?

Benjamin A Fisher, Paul Emery, Costantino Pitzalis, Michele Bombardieri, Simon J Bowman

doi: 10.1136/annrheumdis-2018-213340

April 11, 2018

Correspondence response
Response to: ‘Postpartum breastfeeding status’ by Betzold

Amanda M Eudy, Anna Maria Siega-Riz, Stephanie M Engel, Nora Franceschini, Annie Green Howard, Megan E B Clowse, Michelle Petri

doi: 10.1136/annrheumdis-2018-213427
Correspondence
Postpartum breastfeeding status

Christine Betzold

doi: 10.1136/annrheumdis-2018-213414
Correspondence
Time to personalize the treatment of anti-MDA-5 associated lung disease

Michael Lake, Gautam George, Ross Summer

doi: 10.1136/annrheumdis-2018-213285

April 03, 2018

Correspondence response
Response to: ‘Detection of myositis-specific antibodies: additional notes’ by Infantino et al

Anna Tjärnlund, Ingrid E Lundberg, Johan Rönnelid

doi: 10.1136/annrheumdis-2018-213341
Correspondence response
Response to: ‘Comment on “Evaluation of the impact of concomitant fibromyalgia on TNF alpha blockers’ effectiveness in axial spondyloarthritis: results of a prospective, multicentre study” by Moltó et al: still a long way to go in the assessment of patients with spondyloarthritis and concomitant fibromyalgia?’ by Altobelli et al

Anna Moltó, Maxime Dougados

doi: 10.1136/annrheumdis-2018-213419

March 28, 2018

Correspondence response
Response to: ‘Lack of standardization of ANA and implications for drug development and precision medicine’ by Mahler

David S Pisetsky, Diane M Spencer, Peter E Lipsky, Brad H Rovin

doi: 10.1136/annrheumdis-2018-213399

March 24, 2018

Correspondence
Lack of standardisation of ANA and implications for drug development and precision medicine

Michael Mahler

doi: 10.1136/annrheumdis-2018-213374
Correspondence response
Response to: ’A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease' by Aeschlimann et al

Florence A Aeschlimann, Ronald M Laxer

doi: 10.1136/annrheumdis-2018-213359

March 23, 2018

Correspondence
Checkpoint inhibitors and arthritis

Nicholas Manolios, Leslie Schrieber

doi: 10.1136/annrheumdis-2018-213415
Correspondence
Comment on: ‘Evaluation of the impact of concomitant fibromyalgia on TNF alpha blockers’ effectiveness in axial spondyloarthritis: results of a prospective, multicentre study’ by Moltó et al: still a long way to go in the assessment of patients with spondyloarthritis and concomitant fibromyalgia?

Alessio Altobelli, Rossana Scrivo, Guido Valesini

doi: 10.1136/annrheumdis-2018-213319

March 21, 2018

Correspondence response
Response to: ‘The reference levels of serum urate for clinically evident incident gout’ by Chen and Ding

Nicola Dalbeth, Amanda Phipps-Green, Christopher Frampton, Tuhina Neogi, William J Taylor, Tony R Merriman

doi: 10.1136/annrheumdis-2018-213372
Correspondence
Reference level of serum urate for clinically evident incident gout

Xiao Chen, Xiaoqiang Ding

doi: 10.1136/annrheumdis-2018-213355

March 16, 2018

Correspondence
Response to: ‘A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease’

Florian Berteau, Bénédicte Rouvière, Alice Nau, Rozenn Le Berre, Guillaume Sarrabay, Isabelle Touitou, Claire de Moreuil

doi: 10.1136/annrheumdis-2018-213347

March 13, 2018

Correspondence
Additional response to the correspondence: ‘Switching from the bio-originators to biosimilar: is it premature to recommend this procedure?’ by Cantini and Bennuci

Marc Scherlinger, Thierry Schaeverbeke

doi: 10.1136/annrheumdis-2018-213342
Correspondence response
Response to: ‘The role of temporal artery biopsy in patients with giant cell arteritis is debated’ by Moiseev et al

Christian Dejaco, Sofia Ramiro, Christina Duftner, Wolfgang A Schmidt

doi: 10.1136/annrheumdis-2018-213284
Correspondence
Response to ‘Detection of myositis-specific antibodies: additional notes’

Maria Infantino, Mariangela Manfredi, Valentina Grossi, Maurizio Benucci

doi: 10.1136/annrheumdis-2018-213320

March 09, 2018

Correspondence
Cardiovascular events in ankylosing spondylitis: a 2018 meta-analysis

Sylvain Mathieu, Martin Soubrier

doi: 10.1136/annrheumdis-2018-213317
Correspondence response
Cell function in disease: there are more than two parties at play

Jacques Behmoaras, Enrico Petretto

doi: 10.1136/annrheumdis-2018-213121
Correspondence
Can ultrasound of the major salivary glands assess histopathological changes induced by treatment with rituximab in primary Sjögren’s syndrome?

Esther Mossel, Konstantina Delli, Suzanne Arends, Erlin A Haacke, Bert van der Vegt, Jolien F van Nimwegen, Alja J Stel, Fred K L Spijkervet, Arjan Vissink, Frans G M Kroese, Hendrika Bootsma

doi: 10.1136/annrheumdis-2018-213332

March 06, 2018

Correspondence
Forward to the past: ultrasound might be necessary in some patients with rheumatoid arthritis

Ottar Gadeholt

doi: 10.1136/annrheumdis-2018-213278

March 02, 2018

Correspondence
The role of temporal artery biopsy in patients with giant-cell arteritis is debated

Sergey V Moiseev, Ilya Smitienko, Nikolay Bulanov, Pavel I Novikov

doi: 10.1136/annrheumdis-2018-213282

February 22, 2018

Correspondence response
Examination of the elephant

Rohit Aggarwal, Chester V Oddis

doi: 10.1136/annrheumdis-2018-213020

February 16, 2018

Correspondence
Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis

Hui-Zi Li, Xiang-He Xu, Nan Lin, Hua-Ding Lu

doi: 10.1136/annrheumdis-2018-213157

February 14, 2018

Correspondence response
Response to: ‘Bisphosphonates reduce the risk of knee replacement: we need more analyses!’ by Li et al

Tuhina Neogi, Shanshan Li, Christine Peloquin, Devyani Misra, Yuqing Zhang

doi: 10.1136/annrheumdis-2018-213094
Correspondence
Detection of myositis-specific antibodies: additional notes

Michael Mahler, Marvin J Fritzler

doi: 10.1136/annrheumdis-2018-213153

February 09, 2018

Correspondence
M-CSF and GM-CSF monocyte-derived macrophages in systemic sclerosis: the two sides of the same coin?

Alain Lescoat, Patrick Jégo, Valérie Lecureur

doi: 10.1136/annrheumdis-2018-213112

February 07, 2018

Correspondence
Bisphosphonates reduce the risk of knee replacement: we need more analyses!

Hui-Zi Li, Xiang-He Xu, Hua-Ding Lu

doi: 10.1136/annrheumdis-2018-213052

February 06, 2018

Correspondence response
Response to: ‘Can we prescribe TMP/SMX prophylaxis without any concerns equally for all patients with rheumatic disease?’ by Suyama and Okada

Jun Won Park, Jeffrey R Curtis, Eun Bong Lee

doi: 10.1136/annrheumdis-2018-213045
Correspondence
Can we prescribe TMP/SMX prophylaxis without any concerns equally for all patients with rheumatic disease?

Yasuhiro Suyama, Masato Okada

doi: 10.1136/annrheumdis-2018-213027

February 02, 2018

Correspondence response
Response to: ‘Seeing the glass either half full or half empty: response to the correspondence ’Switching from the bio-originators to biosimilar: is it premature to recommend this procedure?'' by Scherlinger and Schaeverbeke

Fabrizio Cantini, Maurizio Benucci

doi: 10.1136/annrheumdis-2018-213044

January 29, 2018

Correspondence response
Response to: ‘Association between bisphosphonate use and risk of undergoing knee replacement in osteoarthritis patients’ by Chen et al

Tuhina Neogi, Shanshan Sheehy, Christine Peloquin, Devyani Misra, Yuqing Zhang

doi: 10.1136/annrheumdis-2018-213018

January 26, 2018

Correspondence response
Response to: ‘Switching from the bio-originators to biosimilar: is it premature to recommend this procedure?’ by Cantini and Benucci

Marc Scherlinger, Thierry Schaeverbeke

doi: 10.1136/annrheumdis-2018-213021

January 25, 2018

Correspondence
Association between bisphosphonate use and risk of undergoing knee replacement in patients with osteoarthritis

Yan Chen, Jinmin Zhao, Shan Lao, Weijia William Lu

doi: 10.1136/annrheumdis-2018-212998

January 23, 2018

Correspondence
Elephant in the room

Daniel M Hartung, Kirbee Johnston, David M Cohen, Thuan Nguyen, Atul A Deodhar, Dennis N Bourdette

doi: 10.1136/annrheumdis-2018-213008

January 22, 2018

Correspondence
Response to: ‘Statins in systemic lupus erythematosus’ by Abud-Mendoza

Hilda J I de Jong, Tjeerd P van Staa, Jan Willem Cohen Tervaert

doi: 10.1136/annrheumdis-2017-212902

January 02, 2018

Correspondence
Inconsistency between Danish incidence and prevalence data about psoriatic arthritis (PsA)

Philipp Sewerin, Annika Hoyer, Matthias Schneider, Benedikt Ostendorf, Ralph Brinks

doi: 10.1136/annrheumdis-2017-212817

December 29, 2017

Correspondence
Switching from the bio-originators to biosimilar: is it premature to recommend this procedure?

Fabrizio Cantini, Maurizio Benucci

doi: 10.1136/annrheumdis-2017-212820

Log in using your username and password

Main menu

Log in using your username and password

You are here

Online First

May 14, 2018

May 05, 2018

May 03, 2018

April 28, 2018

April 25, 2018

April 20, 2018

April 17, 2018

April 13, 2018

April 11, 2018

April 03, 2018

March 28, 2018

March 24, 2018

March 23, 2018

March 21, 2018

March 16, 2018

March 13, 2018

March 09, 2018

March 06, 2018

March 02, 2018

February 22, 2018

February 16, 2018

February 14, 2018

February 09, 2018

February 07, 2018

February 06, 2018

February 02, 2018

January 29, 2018

January 26, 2018

January 25, 2018

January 23, 2018

January 22, 2018

January 02, 2018

December 29, 2017

Pages